Gender affirming hormone therapy and transgender women fertility: Histologic predictors of germ cell presence.

Lina Rigodanzo Marins Tiago Elias Rosito Lúcia Maria Kliemann Edison Capp Helena von Eye Corleta

Published in: Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia (2024)

Cross-sex hormone treatment affects testicular germ cell presence. Basal membrane length and tubular diameter ratio reduces inter variability of measurements and better exemplify how atrophic seminiferous tubules are. Fertility preservation should be addressed by healthcare providers in order to recognize gender affirming treatment impact on transgender health.

Keyphrases

germ cell
healthcare
mental health
stem cells
metabolic syndrome
mesenchymal stem cells
replacement therapy
skeletal muscle
polycystic ovary syndrome
risk assessment
endothelial cells
hiv testing
optical coherence tomography
cell therapy
health promotion